Could a tiny dose of dexmedetomidine double Pain-Free time after surgery?
NCT ID NCT07651488
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether adding a small dose of dexmedetomidine to a standard spinal anesthetic (bupivacaine) can extend pain relief for adults undergoing perianal surgery. One hundred participants aged 40–80 will receive either the standard anesthetic alone or with dexmedetomidine. The main goal is to see how long pain relief lasts and whether it reduces the need for additional pain medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine
- What this could lead to
- If it works, this could provide longer-lasting pain relief after perianal surgery, reducing the need for additional painkillers.
- What could go wrong
- This is a very early-phase trial with only 100 participants, so results may not apply broadly. Adding dexmedetomidine may also increase side effects like drowsiness or low blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DURATION OF ANALGESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Liaquat National Hospital
Karachi, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.